ArticleBone marrow transplantation2026

Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.

Laura B Oswald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.